α-Lipoic acid mitigates insulin resistance in Goto-Kakizaki rats

Hormone and Metabolic Research

Volumn 36, Issue 8, 2004, Pages 542-549

  Bitar, M S ^a   Wahid, S ^a   Pilcher, C W T ^a   Al Saleh, E ^a   Al Mulla, F ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

lipoic Acid; Goto Kakizaki Rats; Insulin Resistance; Type II Diabetes

Indexed keywords

INSULIN; INSULIN RECEPTOR SUBSTRATE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; THIOCTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GLUCOSE METABOLISM; GLUCOSE OXIDATION; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; HORMONE ACTION; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RAT; RAT STRAIN; SIGNAL TRANSDUCTION; SOLEUS MUSCLE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANTIOXIDANTS; BIOLOGICAL TRANSPORT; DIABETES MELLITUS, TYPE 2; GLUCOSE; INSULIN; INSULIN RESISTANCE; MALE; MUSCLE, SKELETAL; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, INBRED STRAINS; RATS, WISTAR; THIOCTIC ACID;

ANIMALIA;

EID: 4544259657     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-825760     Document Type: Article

References (70)

1. Olefsky JM, Kolterman OG. Scarlwtt JA. Insulin action and resistance in obesity and non-insulin-dependent type II diabetes mellitus. Am J Physiol 1982; 243: E15-E30
2. Shepherd PR, Kahn BB. Glucose transporters and insulin action: implications for insulin resistance and diabetes mellitus. N Engl J Med 1999; 341: 248-257
3. Hamman RF. Genetic and environmental determinations of non-insulin-dependent diabetes mellitus (NIDDM). Diabetes. Metab. Rev 1992; 8: 287-338
4. Kahn CR. The molecular mechanisms of insulin action. Annu Rev Med 1985; 36: 429-451
5. Reavon GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607
6. De Fronzo RA. Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipedemia and atherosclerotic cardiovascular disease. Diabetes care 1991; 14: 173-194
7. Kraus W. Insulin resistance syndrome and cardiovascular disease: Genetic and connections to skeletal muscle function. Am Heart J 1999; 138: 413-416
8. De Fronzo RA. Lilly lecture 1987: The triumvirate: β-cell, muscle, liver: a collusion responsible for NIDDM. Diabetes 1988; 37: 667-687
9. Dombrowski L, Roy D, Marcottee B, Marette A. A new procedure for the isolation of plasma membrane, T tubules and internal membranes from skeletal muscle. Am J Physiol 1996; 270: E667-E676
10. Czech MP, Corvera S. Signaling mechanisms that regulates glucose transport. J Biol Chem 1996; 274: 1865-1868
11. Zorzano A, Munoz P, Camps M, Mora C, Testar X, Palacin M. Insulin induced redistribution of GLUT4 glucose carriers in the muscle fibre in search of GLUT4 trafficking pathways. Diabetes 1996; 45: S70-S81
12. Sun XJ, Pons S, Asano T, Myers MG, Jr, Glasheen EM, White MF. The Fyn Tyrosine Kinase Binds Irs-1 and Forms a Distinct Signaling Complex during Insulin Stimulation. J Biol Chem 1996; 271: 10583-10587
13. Beitner-Johnson D, Blakesley VA, Shen-Orr Z, Jimenez M, Stannard B, Wang LM, Pierce JH, Le Roith D. The Proto-oncogene Product c-Crk Associates with Insulin Receptor Substrate-1 and 4PS. J Biol Chem 1996; 271: 9287-9290
14. Shepherd PR, Withers DJ, Siddle K. Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. Biochem J 1998; 333: 471-490
15. Tirosh A, Rudich A, Potashinik R, Bashan N. Oxidative stress impairs insulin but not platelet-derived growth factor signalling in 3T3-L1 adiopocytes. Biochem. J 2001; 355: 757-763
16. Blair AS, Hajduch E, Litherland GJ, Hundal HS. Regulation of glucose transport and glycogen synthesis in L6 muscle cells during oxidative stress. J Biol Chem 1999; 274: 36 293-36 299
17. Jacob S, Henriksen EJ, Schiemann AL et al. Enhancement of glucose disposal in patients with type II diabetes by alpha-lipoic acid. Arzneimittelforschung 1995; 45: 872-874
18. Caballero B. Vitamin E improves the action of insulin. Nutr Rev 1993; 51: 319-340
19. Paolisso GD, Amore A, Bulbi V et al. Plasma vitamin C affects glucose homeostasis in healthy subjects and in non-insulin dependent diabetics. Am J Physiol 1994; 266: E261-E268
20. Goto Y, Kakizaki M, Masaki N. Production of spontaneous diabetic rats by repetition of selective breeding. Tohoku J Exp Med 1975; 119: 85-90
21. Goto Y, Kakizaki M, Masaki N. Spontaneous diabetes produced by selective breeding of normal Wistar rats. Proc J Jpn Acad 1975; 5: 80-85
22. Goto Y, Suzuki KI, Sasaki M, Ono T, Abe S. GK rat as a model of non obese, non insulin dependent diabetes: Selective breeding over 35 generations In: Shafir E, Renold AE, (eds). Frontiers in Diabetes Research. Lessons from Animal Diabetes 11. London: John Libbey, 1988: 301-303
23. Henriksen EJ, Tischler ME. Time course of the response of carbohydrate metabolism to unloading of the soleus. Metabolism 1988; 37: 201-208
24. Gulve EA, Henriksen EJ, Rodnick KJ, Youn JH, Hollozy JO. Glucose transporters and glucose transport in skeletal muscles of 1 to 25 month old rats. Am J Physiol 1993; 264: E319-E327
25. Hadari YR, Tzahar E, Nadiv O, Rothenberg P, Roberts CT, Jr, Le Roith D, Yarden Y, Zick Y. Insulin and insulinomimetic agents induce activation of phosphatidylinositol 3-kinase upon its association with pp 185 (IRS-1) in intact rat liver. J Biol Chem 1992; 267: 17483-17486
26. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. Inhibition of glycogen synthetase kinase-3 by insulin-mediated by protein kinase B. Nature 1995; 378: 785-789
27. Tanti JF, Grillo S, Gremeau T, Coffer PJ, Van Obberghen E, Le Marchand-Brustel Y. Potential role of protein kinase B in glucose transporter 4 translocation in adipocytes. Endocrinology 1997; 138: 2005-2010
28. Harano Y, Ohgaku S, Kosugi K, Yasuda H, Nakano T, Kobayashi M, Hiduka H, Izumi K, Kashiwagi A, Shigeta Y. Clinical significance of altered insulin sensitivity in diabetes mellitus assessed by glucose, insulin and somatostatin infusion. J Clin Endocrinol Meta 1981; 52: 982-987
29. Perez-Martin A, Raynaud E, Hentgen C, Bringer J, Mercier J, Brun JF. Simplified measurement of insulin sensitivity with the minimal model procedure in type 2 diabetic patients without the measurement of insulinemia. Horm Metab Res 2002; 34: 102-106
30. Levine RL, Garland D, Oliver CW et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990; 186: 464-478
31. Reznick AZ, Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 1994; 233: 357-363
32. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein Measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-275
33. Shepherd PR, Withors DJ, Siddle K. Phosphoinositide 3-kinase: The key switch mechanism in insulin signalling. Biochem J 1998; 333: 471-490
34. Davies KJ. Protein damage and degredation by oxygen radicals. I. General aspects. J Biol Chem 1987; 262: 9895-9901
35. Fucci L, Oliver CN, Coon M, Stadtman ER. Inactivation of key metabolic enzymes by mixed function oxidation reaction: possible implication in protein turnover and aging. Proc Natl Acad Sci USA 1983; 80: 1521-1525
36. Oliver CN, Starke-Reed PE, Stadtman ER, Liu GJ, Carey JM, Floyd RA. Oxidative damage to brain protein, loss of glutamine synthetase activity and production of free radical during ischemia/reperfusion-induced injury to gerbil brain. Proc Natl Acad Sci USA 1990; 87: 5144-5147
37. Jacob S, Streeper RS, Fogt DL, Hokama JY, Tritschler HJ, Dietze GL, Henriksen EJ. The antioxidant α-lipoic acid enhances insulin-stimulated glucose metabolism in insulin-resistant rat skeletal muscle. Diabetes 1996; 45: 1024-1029
38. Yu C, Chew Y, Cline GW et al. Mechanism by which fatty acids inhibits insulin activation of insulin receptor substrate-1 (IRS-1) associated phosphatidyl inositol 3-kinase activity in muscle. J Biol Chem 2002; 277: 50230-50236
39. Kosaki A, Yamada K, Suga A, Kuzuya H. 14-3-3beta protein associates with insulin receptor substrate 1 and decreases insulin stimulated phosphatidyl inositol 3-kinase activity in 3T3L1 adipocytes. J Biol Chem 1998; 273: 940-944
40. Burgering B, Coffer P. Protein kinase B(c-Akt) in phospholidylinositol-3- OH kinase signal transduction. Nature 1995; 376: 599-602
41. Frank T, Yang S, Chan T, Datta K, Kazlauskas A, Morrison D, Kaplan D, Tsichlis P. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphotidylinositol 3-kinase. Cell 1995; 81: 727-736
42. Kohn A, Kovacina K, Roth R. Insulin stimulates the kinase activity of RAC-PK, a pleckstrin homology domain containing serthr kinase. EMBO J 1995; 14: 4288-4295
43. Didichenko S, Tilton B, Hemmings B, Ballmer-Hofer K, Thelen M. Constitutive activation of protein kinase B and phosphorylation of p47 phox by a membrane-targeted phosphoinositide 3-kinase. Curr Biol 1996; 6: 1271-1278
44. Klippel A, Reinhard C, Kavanaugh W, Appell G, Escobedo M, Williams L. Membrane localization of phosphatidylinositol 3-kinase is sufficient to activate multiple signal transducting kinase pathways. Mol Cell Biol 1996; 16: 4117-4127
45. Wang Q, Somwar R, Bilan PJ, Liu Z, Jin J, Woodgeth JR, Klip A. Protein kinase B Akt participates in GLUT4 translocation by insulin in L6 myoblasts. Mol Cell Biol 1999; 19: 4008-4018
46. Song X, Kawano Y, Krook A, Ryder J, Efendic S, Roth R, Wallberg-Henriksson H, Zierath J. Muscle fiber type-specific defects in insulin signal transduction to glucose transport in diabetic GK rats. Diabetes 1999; 48: 664-670
47. Nawano M, Ueta K, Oku A, Arakawa K, Saito A, Funaki M, Anai M, Kikuchi M, Oka Y, Asano T. Hyperglycemia impairs the insulin signalling step between PI 3-kinase and Akt/PKB activation in ZDF rat liver. Biochem Biophys Res Commun 1999; 266: 252-256
48. Oku A, Nawano M, Ueta K et al. Inhibitory effect of hyperglycemia on insulin-induced Akt/protein kinase B activation in skeletal muscle. Am J Physiol 2001; 280: E816-E-825
49. Krook A, Roth RA, Jiang XJ, Zierath JR, Wallberg-Henriksson H. Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from NIDDM subjects. Diabetes 1998; 47: 1281-1286
50. Cohen P, Alessi DR, Cross DAE. PDK1, one of the missing links in insulin signal transduction. FEBS Lett 1997; 410: 3-10
51. Bellacosa A, Chan TO, Ahmed NN, Datta K, Malstrom S, Stokoe D, McCormick F, Feng J, Tsichlis P. Akt activation by growth factor is a multiple-step process: the role of the PH domain. Oncogene 1998; 17: 313-325
52. Downward J. Lipid-regulated kinases: some common themes at last. Science 1998; 279: 673-674
53. Phillay TS, Xiao S, Olefsky JM. Glucose-induced phosphorylation of the insulin receptor. Functional effects and characterization of phosphorylation sites. J Clin Invest 1996; 97: 613-620
54. Muller HK, Kellerer M, Ermel B, Muhlhofer A, Obermaier KB, Vogt B, Haring HU. Prevention by protein kinase C inhibitors of glucose-induced insulin-receptor tynosine. Kinase resistance in rat fat cells. Diabetes 1991; 40: 1440-1448
55. Ruderman NB, Saha AK, Vavvas D, Heydrick SJ, Kurowski TG. Lipid abnormalities in muscle of insulin-resistant rodents: the malonyl COA hypothesis. Ann NY Acad Sci 1996; 827: 221-230
56. Laybutt DR, Schmitz-Peiffer C, Saha AK, Ruderman NB, Chisholm D, Biden T, Kraegen EW. Activation of protein kinase C may contribute to muscle insulin-resistance induced by lipid accumulation during chronic glucose infusion in rats (Abstract). Diabetes 1997; 46: 241A
57. Barthel A, Nakatani K, Dandekar A, Roth RA. Protein kinase C modulates the insulin-stimulated increase in Akt 1 and Akt 3 activity in 3T3-L1 adipocytes. Biochem Biophys Res Commun 1998; 243; 509-513
58. Tirosh A, Potashnik R, Bashan N, Rudich A. Oxidative stress disrupts insulin-induced cellular redistribution of insulin receptor substrate-1 and phosphotidylinositol 3-kinase in 3T3 adipocytes: A putative cellular mechanism for impaired protein kinase B activation and GLUT4 translocation. J Biol Chem 1999; 274: 10595-10602
59. 2 in tumor necrosis factor alpha-mediated insulin resistance. J Biol Chem 1999; 274: 25 078-25 084
60. Maddux BA, See W, Lawrence JC, Goldfine AL, Goldfine ID, Evans JL. Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by micromolar concentrations of α-lipoic acid. Diabetes 2001; 50: 404-410
61. Rosen P, Naworth PP, King G, Moller W, Tritschler HJ, Packer L. The role of oxidative stress in the onset and progression of diabetes and its complications. Diabetes Metab Res Rev 2001; 17: 189-212
62. Brownlee M. Biochemistry and Molecular cell biology of diabetic complications. Nature 2001; 414: 813-820
63. Gopaul NK, Manraj MD, Hebe A, Lee Kwai Yan S, Johnston A, Carrier MJ, Anggard EE. Oxidative stress could precede endothelial dysfunction and insulin resistance in Indian Mauritians with impaired glucose metabolism. Diabetologia 2001; 44: 706-712
64. Biewenga GP, Haenen GR, Bast A. The Pharmacology of the antioxidant lipoic acid. Gen Pharmacol 1997; 29: 315-331
65. Packer L, Witt EH, Tritchler HJ. Alpha-lipoic acid as a biological antioxidant free. Radic Biol Med 1995; 19: 227-250
66. Haugaard N, Haugaard ES. Stimulation of glucose utilization by thioctic acid in rat diaphragm incubated in vitro. Biochem Biophys Acta 1970; 222: 583-586
67. Ramrath S, Tritschler HJ, Eckel J. Stimulation of cardiac glucose transport by thioctic acid and insulin. Horm Metab Res 1999; 31: 632-635
68. Evans JL, Goldfine ID. α-lipoic acid: a multifactorial antioxidant that improves insulin sensitivity in patients with type 2 diabetes. Diabetes. Technol Thr 2000; 2: 401-414
69. Khamaisi M, Potashnik R, Tirosh A, Demshchak E, Rudich A, Tritschler H, Wessel K, Bashan N. Lipoic acid reduces glycemia and increases muscle GLUT4 content in streptozotocin-diabetes rats. Metabolism 1997; 46: 763-768
70. Fujimoto WY. The importance of insulin resistance in the pathogenesis of type 2 diabetes mellitus. Am J Med 2000; 108 (suppl 6a): 9S-14S